Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses
Science Advances · 2023
DOI: 10.1126/sciadv.adf4975 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Ben Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany. Hauptthemen laut MEDLINE: COVID-19, Interferon Type I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Epithelial immune responses govern tissue homeostasis and offer drug targets against maladaptation. Here, we report a framework to generate drug discovery–ready reporters of cellular responses to viral infection. We reverse-engineered epithelial cell responses to SARS-CoV-2, the viral agent fueling the ongoing COVID-19 pandemic, and designed synthetic transcriptional reporters whose molecular logic comprises interferon-α/β/γ and NF-κB pathways. Such regulatory potential reflected single-cell data from experimental models to severe COVID-19 patient epithelial cells infected by SARS-CoV-2. SARS-CoV-2, type I interferons, and RIG-I drive reporter activation. Live-cell image–based phenotypic drug screens identified JAK inhibitors and DNA damage inducers as antagonistic modulators of epithelial cell response to interferons, RIG-I stimulation, and SARS-CoV-2. Synergistic or antagonistic modulation of the reporter by drugs underscored their mechanism of action and convergence on endogenous transcriptional programs. Our study describes a tool for dissecting antiviral responses to infection and sterile cues and rapidly discovering rational drug combinations for emerging viruses of concern.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany.
- Helmholtz-Zentrum für Infektionsforschung GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany.
ORCID-Profile: Ben Jiang, Matthias Jürgen Schmitt, Ulfert Rand, Carlos Company, Yuliia Dramaretska, Michela Serresi, Luka Čičin-Šain, Gaetano Gargiulo
Zitieren
APA
Jiang, B., Schmitt, M. J., Rand, U., Company, C., Dramaretska, Y., Grossmann, M., Serresi, M., Čičin-Šain, L., & Gargiulo, G. (2023). Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses. Science Advances. https://doi.org/10.1126/sciadv.adf4975
Vancouver
Jiang B, Schmitt MJ, Rand U, Company C, Dramaretska Y, Grossmann M, et al. Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses. Science Advances. 2023. doi:10.1126/sciadv.adf4975
BibTeX
@article{Jiang2023,
author = {Jiang, Ben and Schmitt, Matthias Jürgen and Rand, Ulfert and Company, Carlos and Dramaretska, Yuliia and Grossmann, Melanie and Serresi, Michela and Čičin-Šain, Luka and Gargiulo, Gaetano},
title = {Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.adf4975}
}
EUVIMED